Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
There are limited treatment options for infection with the respiratory syncytial virus. In this human challenge model, a new oral nucleoside analogue, ALS-008176, showed modest antiviral activity.
Respiratory syncytial virus (RSV) infections are a cause of substantial morbidity and mortality in various patient populations worldwide, including ch...
Alternative Titles
Full title
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1735333457
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1735333457
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1413275
